Bicalutamide (`Casodex¿) 150mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme

• Autores: William A. See, Jon Armstrong, Manfred P. Wirth, Chris J. Tyrrell, Clive Morris, Heather Payne, David G. McLeod, Peter Iversen
• Localización: Radiotheraphy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology, ISSN 0167-8140, Vol. 76, Nº. 1, 2005, págs. 4-10
• Idioma: inglés
• Texto completo no disponible (Saber más ...)